Atea Pharmaceuticals

Atea

This biopharmaceutical company develops oral antiviral therapies for patients with serious viral infections, including hepatitis C and other ribonucleic acid virus diseases.

Antios Therapeutics

This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.

Altesa BioSciences

This company develops antiviral medicines for patients with chronic lung diseases such as COPD and asthma to prevent respiratory infections and illness flare-ups.

Enanta

This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.

AusperBio

This biopharmaceutical company develops oligonucleotide therapies and targeted delivery platforms for patients with chronic hepatitis B and other genetic or viral diseases.

Inventiva

This biopharmaceutical company develops oral small molecule therapies for patients with metabolic dysfunction-associated steatohepatitis and other fibrotic or metabolic diseases.

Bluejay Therapeutics

The company develops monoclonal antibody therapies and small molecule drugs to treat patients with chronic hepatitis B, hepatitis D and other liver diseases.

Pharmasset

This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.